Search results for "Class"

showing 10 items of 38174 documents

Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer

2007

Abstract Background. Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) contribute to the invasiveness of many carcinomas. Here, we studied a possible association between cytosolic uPA and PA-1 concentrations in tumor tissue with prognosis in patients with endometrial cancer. Methods. Cytosolic concentrations of uPA and PAI-1 were determined in 69 primary endothelial adenocarcinomas using an enzyme-linked immunoassay (ELISA). A possible influence of uPA and PAI-1 was studied by multivariate Cox regression adjusting for the established clinical prognostic factors FIGO-stage, grading, depth of invasion, diabetes mellitus and age. Results. Both uPA ( …

medicine.medical_specialtymedicine.drug_classAdenocarcinomaDisease-Free SurvivalMetastasisPredictive Value of TestsGermanyInternal medicineDiabetes mellitusPlasminogen Activator Inhibitor 1Progesterone receptorBiomarkers TumormedicineHumansNeoplasm StagingUrokinasebusiness.industryProportional hazards modelEndometrial cancerObstetrics and GynecologyMiddle AgedPrognosismedicine.diseaseSurvival AnalysisUrokinase-Type Plasminogen ActivatorEndometrial NeoplasmsEndocrinologyOncologyEstrogenFemalebusinessPlasminogen activatormedicine.drugGynecologic Oncology
researchProduct

Clinical pharmacokinetics of atenolol — A review

1982

Atenolol is a hydrophilic betareceptor blocking drug, which is predominantly eliminated via the kidneys, only about 5% of the atenolol is metabolised by the liver. After oral administration atenolol is incompletely absorbed from the intestine, so about 50% of the beta blocker are finally biovailable. In plasma only 3% of atenolol are protein-bound. There exists a linear relationship between the atenolol plasma levels and the degree of beta blocking effect measured by inhibition of the exercise-induced tachycardia. No correlation was found between plasma levels of atenolol and blood pressure lowering activity of the drug. After oral administration elimination half life of atenolol is calcula…

medicine.medical_specialtymedicine.drug_classAdministration OralBiological AvailabilityRenal functionPharmacologyKidneyIntestinal absorptionPropanolaminesPharmacokineticsRenal DialysisOral administrationInternal medicinemedicineHumansDrug InteractionsPharmacology (medical)cardiovascular diseasesBeta blockerPharmacologyChemistryLiver DiseasesKidney metabolismAtenololKineticsEndocrinologyAtenololIntestinal AbsorptionInjections IntravenousKidney DiseasesBiological half-lifecirculatory and respiratory physiologymedicine.drugEuropean Journal of Drug Metabolism and Pharmacokinetics
researchProduct

The early response of the postmenopausal endometrium to tamoxifen: expression of estrogen receptors, progesterone receptors, and Ki-67 antigen

2003

OBJECTIVE To enlighten the early response of endometrium to tamoxifen by assessing the expression of estrogen receptors, progesterone receptors, Ki-67, and the histological response in endometria from normal postmenopausal women treated for 21 days with tamoxifen. DESIGN A total of 40 women, scheduled to undergo vaginal hysterectomy because of uterine prolapse, were randomly assigned to the tamoxifen group (20 mg/day; 20 women) or the control group (20 women). Samples were obtained from the upper and the lower thirds of the uterine cavity. Standard immunohistochemical staining of estrogen and progesterone receptors and of Ki-67 was performed on frozen sections. Staining was assessed using s…

medicine.medical_specialtymedicine.drug_classAdministration OralEstrogen receptorEndometriumEndometriumInternal medicineProgesterone receptormedicineHumansEstrogen receptor betabusiness.industryAntibodies MonoclonalObstetrics and GynecologyMiddle AgedImmunohistochemistryPostmenopauseTamoxifenKi-67 AntigenEndocrinologymedicine.anatomical_structureReceptors EstrogenEstrogenFemaleSimple Endometrial HyperplasiaReceptors ProgesteronebusinessEstrogen receptor alphahormones hormone substitutes and hormone antagonistsTamoxifenmedicine.drugMenopause
researchProduct

Direct oral anticoagulants for the treatment of pulmonary embolism in patients with renal impairment.

2021

Pulmonary embolism (PE) is associated with adverse outcomes and substantial morbidity and mortality. Patients with PE often have renal impairment because of shared risk factors and close links between the renal and cardiovascular systems. Furthermore, patients with PE and renal impairment are at increased risk of recurrent thrombosis. Therefore, anticoagulation is crucial to treat the acute event, prevent recurrent venous thromboembolism (VTE), and optimize patient outcomes. However, when treated with an anticoagulant, patients with renal impairment also have an elevated risk of bleeding. Direct oral anticoagulants (DOACs) are the first-choice treatment for acute VTE in eligible patients. H…

medicine.medical_specialtymedicine.drug_classAdministration OralHemorrhage030204 cardiovascular system & hematologyurologic and male genital diseases03 medical and health sciences0302 clinical medicineRisk FactorsmedicineHumansIn patientRecurrent thrombosisPatient groupIntensive care medicinebusiness.industryAnticoagulantAnticoagulantsHematologyVenous Thromboembolismmedicine.diseasePulmonary embolismIncreased risk030220 oncology & carcinogenesisRenal physiologybusinessPulmonary EmbolismVenous thromboembolismThrombosis research
researchProduct

Oxidative Stress and Ubiquitin Ligases: their involvement in skeletal muscle atrophy

2015

Introduction Muscle atrophy plays a relevant role in the many very prevalent diseases. Generation of reactive oxygen species (mainly by the xanthine oxidase) and inflammation are two of the main triggers of muscle atrophy. Aim The major aim of our study was to determine the mechanism by which reactive oxygen species activate E3 ubiquitin ligases (MuRF-1 and MAFbx) cause muscle atrophy. Possible prevention by allopurinol, a well-known xanthine oxidase inhibitor widely used in clinical practice; and by indomethacin, a non-steroidal antiinflamatory drug was also studied. Materials and methods Male C57BL/6J mice (3 months old) conditioned by 14 days of hindlimb unloading with or without each tr…

medicine.medical_specialtymedicine.drug_classAllopurinolBiologymedicine.diseaseBiochemistryMuscle atrophyCachexiachemistry.chemical_compoundEndocrinologyAtrophychemistryPhysiology (medical)SarcopeniaInternal medicinemedicinemedia_common.cataloged_instanceEuropean unionmedicine.symptomXanthine oxidaseXanthine oxidase inhibitormedia_commonmedicine.drugFree Radical Biology and Medicine
researchProduct

Assessment of Quality of Life in Postmenopausal Women with Early Breast Cancer Participating in the PACT Trial: The Impact of Additional Patient Info…

2019

<b><i>Background:</i></b> Breast cancer patients’ self-understanding of their disease can impact their quality of life (QoL); the relationship between compliance and QoL is poorly understood. <b><i>Patients and Methods:</i></b> The Patient’s Anastrozole Compliance to Therapy (PACT) program, a prospective, randomized study, investigated the effect of additional patient information material (IM) packages on compliance with adjuvant aromatase inhibitor (AI) therapy in postmenopausal women with hormone receptor-positive early breast cancer. The QoL subanalysis presented here examined the impact of IM packages on QoL and the association between QoL…

medicine.medical_specialtymedicine.drug_classAnastrozoleDiseasePactlaw.invention03 medical and health sciences0302 clinical medicineBreast cancerQuality of lifeRandomized controlled triallawmedicine030212 general & internal medicineAromatase inhibitorbusiness.industryCancermedicine.diseasehumanitiesOncology030220 oncology & carcinogenesisPhysical therapySurgerybusinessResearch Articlemedicine.drugBreast Care
researchProduct

Current methods of sedation in dental patients : a systematic review of the literature

2015

Objetive The main objective of this systematic literature review is to identify the safest and most effective sedative drugs so as to ensure successful sedation with as few complications as possible. Study Design A systematic literature review of the PubMed MEDLINE database was carried out using the key words “conscious sedation,” “drugs,” and “dentistry.” A total of 1,827 scientific articles were found, and these were narrowed down to 473 articles after applying inclusion and exclusion criteria. These 473 studies were then individually assessed for their suitability for inclusion in this literature review. Results A total of 21 studies were selected due to their rigorous study design and c…

medicine.medical_specialtymedicine.drug_classAnesthesia DentalMidazolamSedationConscious SedationMEDLINEReview03 medical and health sciences0302 clinical medicinemedicineHumansHypnotics and Sedatives030212 general & internal medicineDexmedetomidineIntensive care medicinePropofolGeneral Dentistrybusiness.industry030206 dentistryMedically compromised patients in Dentistry:CIENCIAS MÉDICAS [UNESCO]Systematic reviewOtorhinolaryngologyAnesthesiaSedativeUNESCO::CIENCIAS MÉDICASInclusion and exclusion criteriaMidazolamSurgerymedicine.symptomPropofolbusinessmedicine.drug
researchProduct

A conservative treatment for chronic obstructive sialoadenitis by intraductal instillation of mucolytic, steroids and antibiotic solution

2021

Abstract Purposes Reporting our experience in treating chronic obstructive sialadenitis with a protocol consisting of sialoendoscopy and intraductal instillation of antibiotics, steroids and n-acetyl-cysteine (NAC) solution. Methods Prospective study of patients with chronic obstructive sialadenitis with no apparent lithiasic obstructions, with recurrent non-lithiasic sialoadenitis and patients with lithiasic sialoadenitis not solved with sialoendoscopy. In all cases, a sialoendoscopy was performed. All the patients affected by lithiasic sialoadenitis where the chronic inflammation was resolved with sialoendoscopy were excluded from the study. The mid-term follow-up was performed at 12 mont…

medicine.medical_specialtymedicine.drug_classAntibioticsConservative TreatmentIntraductal instillationSialadenitisChronic obstructive sialadenitismedicineHumansProspective StudiesSialoendoscopyProspective cohort studyExpectorantsbusiness.industryEndoscopyGeneral Medicinemedicine.diseaseSialadenitisSurgeryMiscellaneousAnti-Bacterial AgentsConservative treatmentOtorhinolaryngologyOtorhinolaryngologySialoendoscopyBetamethasoneSteroidsNeurosurgerybusinessmedicine.drug
researchProduct

Cis-diaminedichloro platinum ototoxicity. An experimental study.

1985

Four groups of guinea pigs received different doses of cis-platinum. SEM and TEM showed a direct relation between the dose and the damage. The first row of OHC is the first one to be damaged. The IHC are more resistant than the OHC. The pattern of destruction is similar to the one produced by the aminoglucoside antibiotics.

medicine.medical_specialtymedicine.drug_classAntibioticsGuinea Pigschemistry.chemical_elementCis-platinumPharmacologyInjections IntramuscularOtotoxicityHair Cells AuditoryMedicineAnimalsHearing LossOrgan of Cortibusiness.industryGeneral Medicinemedicine.diseaseSurgeryMicroscopy Electronmedicine.anatomical_structureOtorhinolaryngologychemistryOrgan of CortiToxicityMicroscopy Electron ScanningKidney Diseasessense organsCisplatinbusinessPlatinumInjections IntraperitonealActa oto-laryngologica
researchProduct

[Antimicrobically coated venous catheters--must? Contra].

2002

medicine.medical_specialtymedicine.drug_classAntibioticsMEDLINEDrug resistanceCritical Care and Intensive Care MedicineCatheterizationAnti-Infective AgentsmedicineHumansIntensive care medicineVeinAntibacterial agentbusiness.industryDrug Resistance MicrobialGeneral MedicineBacterial InfectionsSurgeryCatheterAnesthesiology and Pain Medicinemedicine.anatomical_structureEmergency MedicineAnti-Infective Agents LocalAnti-Infective AgentsbusinessComplicationAnasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
researchProduct